Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 10561194)

Published in J Clin Oncol on April 01, 1999


C E Desch1, A B Benson, T J Smith, P J Flynn, C Krause, C L Loprinzi, B D Minsky, N J Petrelli, D G Pfister, M R Somerfield

Author Affiliations

1: American Society of Clinical Oncology. (ASCO) Colorectal Cancer Surveillance Panel, Alexandria, VA 22314, USA.

Articles citing this

Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med (2008) 2.64

Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer (2003) 2.26

Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol (2011) 1.32

Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res (2003) 1.27

Follow-up of gastric cancer: a review. Gastric Cancer (2006) 1.10

Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg (2002) 1.04

Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer (2012) 0.91

Short version of the Guideline: Early Detection of Breast Cancer in Germany. An evidence-, consensus-, and outcome-based guideline according to the German Association of the Scientific Medical Societies (AWMF) and the German Agency for Quality in Medicine (AeZQ). J Cancer Res Clin Oncol (2004) 0.90

The impact of primary care physicians on follow-up care of underserved breast cancer survivors. J Am Board Fam Med (2013) 0.87

Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan. BMC Health Serv Res (2010) 0.87

Follow-up recommendations for colon cancer. Clin Colon Rectal Surg (2005) 0.85

Population-based longitudinal study of follow-up care for patients with colorectal cancer in Nova Scotia. J Oncol Pract (2012) 0.84

A Phase II study of cetuximab (Erbitux) plus FOLFIRI for irinotecan and oxaliplatin-refractory metastatic colorectal cancer. J Korean Med Sci (2007) 0.83

What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea? World J Gastroenterol (2009) 0.81

Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance. Int J Colorectal Dis (2004) 0.78

Economic disparities in treatment costs among ambulatory Medicaid cancer patients. J Natl Med Assoc (2004) 0.77

Colon Cancer Staging in Vulnerable Older Adults: Adherence to National Guidelines and Impact on Survival. Ann Hematol Oncol (2015) 0.75

Life After Cancer. Med J Armed Forces India (2011) 0.75

Articles by these authors

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60

Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22

Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol (2006) 4.75

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60

The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science (1986) 4.40

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09

Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol (2000) 4.01

Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91

The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87

Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38

Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst (2000) 3.27

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.25

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci U S A (2002) 3.16

Telling the truth about terminal cancer. JAMA (1998) 3.07

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.06

It is now the age to define the appropriate follow-up of primary breast cancer patients. J Clin Oncol (1994) 3.00

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol (1999) 2.97

Methodologic lessons learned from hot flash studies. J Clin Oncol (2001) 2.82

Antiviral agent blocks breathing of the common cold virus. Proc Natl Acad Sci U S A (1998) 2.71

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54

Crystal structure of human rhinovirus serotype 1A (HRV1A). J Mol Biol (1989) 2.49

Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47

Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation (2001) 2.46

Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells. J Exp Med (1967) 2.46

Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. J Clin Oncol (2001) 2.43

Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol (1992) 2.42

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol (1993) 2.42

The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A (1999) 2.41

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol (2000) 2.39

Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol (1993) 2.39

A retrospective cohort study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis (1988) 2.38

American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol (1999) 2.35

Can 40 seconds of compassion reduce patient anxiety? J Clin Oncol (1999) 2.33

Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc Natl Acad Sci U S A (1988) 2.30

Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol (1998) 2.24

Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol (2000) 2.11

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08

Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08

A case-control study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis (1987) 2.07

American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol (1999) 2.03

Death in the dental chair: an avoidable catastrophe? Br J Anaesth (1998) 2.01

Encephalopathy and fatty degeneratiof on the viscera in northeastern Thailand. Clinical syndrome and epidemiology. Pediatrics (1971) 2.00

The role of autolysins during vegetative growth of Bacillus subtilis 168. Microbiology (1998) 1.97

Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol (2002) 1.96

Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J Virol (1989) 1.92

Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol (2000) 1.92

Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res (2000) 1.86

Concerted nonsyntenic allelic loss in human colorectal carcinoma. Science (1988) 1.81

Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng Des Sel (2010) 1.80

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. Ann Oncol (2006) 1.77

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results. JAMA (1992) 1.77

Physical and biological properties of dengue-2 virus and associated antigens. J Virol (1970) 1.75

Primary signet-ring cell carcinoma of the colon and rectum. Ann Surg Oncol (1996) 1.75

Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol (1990) 1.74

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol (1998) 1.72

Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol (2000) 1.71

Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study. J Clin Oncol (1994) 1.71

Measuring standards of care for early breast cancer in an insured population. J Clin Oncol (1997) 1.71

Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck (1997) 1.71

Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res (2001) 1.69

Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. Gastroenterology (1998) 1.69

Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol (1999) 1.68

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model. N Engl J Med (1991) 1.67

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. Med Oncol (1996) 1.65

Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. J Mol Biol (2005) 1.62

Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther (2011) 1.62

p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers. J Natl Cancer Inst (1996) 1.62

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. J Clin Oncol (2002) 1.62

Pulmonary function in firefighters: acute changes in ventilatory capacity and their correlates. Br J Ind Med (1979) 1.61

Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev (1989) 1.60

Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol (2001) 1.58

Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis (2000) 1.58

Long-term survival in patients with ovarian metastases from colorectal carcinoma. Ann Surg Oncol (1998) 1.57

Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res (1986) 1.55

Mediastinal lymphadenopathy in patients with or without previous malignancy: EUS-FNA-based differential cytodiagnosis in 153 patients. Am J Gastroenterol (2000) 1.55

The cloning and sequence analysis of the aspC and tyrB genes from Escherichia coli K12. Comparison of the primary structures of the aspartate aminotransferase and aromatic aminotransferase of E. coli with those of the pig aspartate aminotransferase isoenzymes. Biochem J (1986) 1.55

Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. J Natl Cancer Inst (1991) 1.55

The efficacy of specimen radiography in evaluating the surgical margins of impalpable breast carcinoma. AJR Am J Roentgenol (1994) 1.54

New approach to the substaging of node-positive colorectal adenocarcinoma. Ann Surg Oncol (1999) 1.53

Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg (1996) 1.52

American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. J Clin Oncol (1999) 1.52

Health, life, and disability insurance and hereditary nonpolyposis colorectal cancer. Am J Hum Genet (1998) 1.51

The effect of cardiopulmonary lymphatic obstruction on heart and lung function. Thorac Cardiovasc Surg (2001) 1.50

Safety, accuracy, and diagnostic yield of needle localization biopsy of the breast performed using local anesthesia. J Am Coll Surg (1994) 1.49

Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer. J Surg Oncol (2009) 1.49

Metastases in small lymph nodes from colon cancer. Arch Surg (1987) 1.49

Modeling particle exposure in U.S. trucking terminals. Environ Sci Technol (2006) 1.49

Dose coefficients for the embryo and foetus following intakes of radionuclides by the mother. J Radiol Prot (2002) 1.47

Hepatic resection for isolated metastasis from colorectal carcinoma. Am J Surg (1985) 1.46

Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292) Cancer J Sci Am (1997) 1.45

The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse. J Clin Oncol (1992) 1.45

Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer (1992) 1.45

Intraoperative endoscopy in the management of patients with colorectal disease. Cancer Invest (1998) 1.44

A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study. Cancer (1993) 1.44